Fomento Económico Mexicano, S.A.B. de C.V. · FMX · FY2025 Q1 · Calendar Q2 2025
FEMSA Q1 FY2025: Growth Amid Softer OXXO Traffic
FEMSA’s diversified growth engines and ongoing store, digital and retail-media investment supported Q1 revenue growth, but softer OXXO traffic and labor-cost pressure temper the case for durable growth until demand and returns on expansion improve.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about FMX FY2025 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The supplied analysis describes 11.1% year-over-year revenue growth and a 54% increase in net income, with FX gains and the PTM sale contributing to the earnings increase. At OXXO Mexico, same-store sales contracted amid consumer, calendar and weather headwinds. Management maintained guidance and emphasized affordability, digital monetization and disciplined store rollout.
Guidance delta
Guidance was maintained. The supplied transcript analysis notes management expects high-single-digit revenue growth for the full year and a sequential OXXO recovery in Q2.
Key takeaways
- Revenue rose year over year, while net income growth was aided by FX gains and the PTM divestiture.
- OXXO Mexico same-store sales weakened amid macro, calendar and weather pressures.
- Gross-margin support came from financial services, retail media and a shift toward value brands.
- Management continues store expansion while highlighting quality and return on investment.
Management priorities
- Expand affordability and value-brand offers in core categories.
- Grow OXXO Nico and continue store openings with attention to site quality and returns.
- Scale retail-media screens and data-driven promotions.
- Develop Spin Premia and OXXO Pay through fintech partnerships; test US prepared-food offerings.
Follow FMX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Nov 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Oct 23, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 16, 2026 |
| B of A Securities | Buy | Neutral | Upgrade | Aug 4, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 14, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 11, 2026 |
| Citigroup | Buy | Neutral | Upgrade | Sep 9, 2025 |
| Morgan Stanley | Equal Weight | Overweight | Downgrade | Aug 19, 2025 |
| Itau BBA | Outperform | Market Perform | Upgrade | Apr 7, 2025 |
| HSBC | Buy | Hold | Upgrade | Feb 9, 2024 |
| Stifel Nicolaus | Buy | Buy | Maintain | Nov 22, 2016 |
| RBC Capital | Overweight | Neutral | Upgrade | May 7, 2015 |
Named analyst price targets
Upside is calculated against the persisted previous close $127.2. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Rodrigo Alcantara | $134 | $128.72 | +5.3% | Oct 23, 2026 |
| Banco Santander | Analyst unavailable | $130 | $119.92 | +2.2% | Aug 11, 2026 |
| Deutsche Bank | Analyst unavailable | $150 | $125.75 | +17.9% | Aug 4, 2026 |
| Barclays | Analyst unavailable | $138 | $127.73 | +8.5% | Jul 29, 2026 |
| Barclays | Analyst unavailable | $130 | $129.01 | +2.2% | Jul 14, 2026 |
| UBS | Analyst unavailable | $139 | $121.18 | +9.3% | May 28, 2026 |
| Barclays | Analyst unavailable | $125 | $119.97 | -1.7% | May 4, 2026 |
| Barclays | Benjamin Theurer | $116 | $111.44 | -8.8% | Feb 10, 2026 |
| Barclays | Analyst unavailable | $105 | $94.36 | -17.5% | Nov 3, 2025 |
| UBS | Rodrigo Alcantara | $111 | $92.69 | -12.7% | Sep 19, 2025 |
| Barclays | Analyst unavailable | $107 | $89.89 | -15.9% | Jul 31, 2025 |
| UBS | Rodrigo Alcantara | $115 | $101.5 | -9.6% | Jul 10, 2025 |
| Morgan Stanley | Ricardo Alves | $138 | $98.18 | +8.5% | Oct 28, 2024 |
| Barclays | Benjamin Theurer | $145 | $117.5 | +14.0% | Jul 15, 2024 |
| HSBC | Carlos Laboy | $158 | $141.64 | +24.2% | Feb 9, 2024 |
Track every rating change on FMX the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationFomento Económico Mexicano, S.A.B. de C.V. (FEMSA) is a diverse multinational enterprise. Its operations include acting as a key bottler, marketer, and distributor of Coca-Cola trademark beverages across a wide territory encompassing Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil, Argentina, and Uruguay. Furthermore, FEMSA is a significant player in the retail sector, managing 20,431 OXXO convenience stores in Mexico, Colombia, Peru, Chile, and Brazil as of December 31, 2021. The company also operates 567 OXXO GAS service stations in Mexico, which supply fuels, motor oils, lubricants, and car care items.…
Historical context
All FMX earningsConsumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CLX The Clorox Company | FY2027 Q1 · Calendar Q4 2026 | +44.9% | +2.2% | Clorox Holds FY27 Outlook as Inflation Pressures Q1 Margins |
| EL The Estée Lauder Companies Inc. | FY2027 Q1 · Calendar Q4 2026 | +42.0% | -4.1% | Estée Lauder raises FY2027 outlook after broad Q1 growth |
| CHD Church & Dwight Co., Inc. | FY2026 Q3 · Calendar Q4 2026 | +2.2% | +1.2% | Church & Dwight raises sales outlook after strong Q3 organic growth |
| CL Colgate-Palmolive Company | FY2026 Q3 · Calendar Q4 2026 | +4.8% | +2.3% | Colgate-Palmolive: Broad Growth and Margin Expansion in Q3 |
Latest beats and misses
Who reports nextBeat on EPS
- TSEMFY2026 Q3 · November 2, 2026+7.5% EPS-6.7% move
- CLXFY2027 Q1 · November 2, 2026+44.9% EPS+2.2% move
- AAPLFY2026 Q4 · November 2, 2026+3.0% EPS-1.8% move
- PLTRFY2026 Q3 · November 2, 2026+8.3% EPS-3.1% move
- ETRFY2026 Q3 · November 2, 2026+14.5% EPS-0.2% move
- OFY2026 Q3 · November 2, 2026+5.7% EPS+1.1% move
Missed on EPS
- VRTXFY2026 Q3 · November 2, 2026-1.2% EPS-1.0% move
- PEGFY2026 Q3 · November 2, 2026-3.4% EPS+0.1% move
- RYAAYFY2027 Q2 · November 2, 2026-0.3% EPS+2.9% move
- GLPIFY2026 Q3 · October 29, 2026-11.5% EPS-1.3% move
- LYBFY2026 Q3 · October 30, 2026-1.2% EPS+5.0% move
- CCJFY2026 Q3 · October 30, 2026-101.4% EPS-7.9% move
Get the FMX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-04-16T03:54:18.633982+00:00
- Polygon adjusted daily market bars · 2026-11-03T12:30:44.141894+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-03T12:30:44.139161+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-03. For educational purposes only; not investment advice.